Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on IDA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106977572A reveals a novel two-step synthesis route for lithocholic acid offering high purity and significant supply chain cost reduction advantages.
Patent CN102603691B reveals high-yield synthesis for influenza intermediates. Reduces hazardous steps and ensures supply chain stability for pharmaceutical manufacturing.
Patent CN117050020B reveals a metal-free iodine-catalyzed route for pyridazine. This method offers high yields and simplified supply chains for agrochemical intermediate manufacturing.
Patent CN111574471B reveals a novel route for 1,3-oxazine fluorides using Selectfluor, offering cost reduction in API manufacturing and improved supply chain reliability.
Discover a novel hypochlorite-based purification method for 16α-hydroxyprednisolone achieving >99.5% purity. Ideal for reliable pharmaceutical intermediate sourcing.
Patent CN112125943A details a novel hypochlorite oxidation method to remove Impurity H, ensuring >99.5% purity for corticosteroid API manufacturing.
Advanced synthesis of 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile. Optimized agrochemical intermediate manufacturing for cost and supply reliability.
Patent CN116239558A reveals a mild one-pot synthesis of Eriodictyol from Hesperetin, eliminating corrosive reagents and enabling scalable pharmaceutical intermediate manufacturing.
Patent CN115838382B enables green synthesis of beta-ketophosphorus oxide with reduced costs and enhanced supply chain reliability for global buyers.
Novel total synthesis of houttuynoid hybrid flavonoids via Pd-catalyzed coupling and oxidative cyclization, offering scalable production for antiviral drug development.
Novel stable glycosylation donor technology enabling mild conditions and orthogonal protection for high-purity pharmaceutical intermediates manufacturing.
Patent CN104313072A details biocatalytic synthesis yielding high ee. Offers supply chain reliability and cost efficiency for global pharmaceutical manufacturing partners.
Patent CN107298694A reveals a novel Obeticholic Acid synthesis route using cholic acid. This breakthrough offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN117402055B reveals a high-yield oxidation-dechlorination route for m-fluorobenzoic acid from waste mother liquor, offering cost-effective pharma intermediate manufacturing.
Discover the patented method for converting acetophenone mother liquor into high-purity m-fluorobenzoic acid. A cost-effective solution for pharmaceutical supply chains.
Patent CN117510469A reveals high-yield route for dabigatran etexilate intermediate ensuring purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel patent CN120229997A enables safer synthesis. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing processes globally.
Novel Boc-protection route for Tulathromycin avoids Pd/C hydrogenation. Enhances supply chain reliability and reduces safety hazards in veterinary antibiotic manufacturing.
Patent CN103951568A details new Salbutamol route offering purity and supply chain advantages for pharmaceutical intermediates manufacturing globally.
Patent CN104529808A reveals low-cost chiral amide synthesis. Enhances supply chain reliability and purity for asymmetric catalysis ligands.